Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in PGEN — Precigen, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,141,413
+$550,674 QoQ
Shares Held
200,248
+31.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. PGEN ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,141,413 200,248
2026-03-31 $590,739 152,646
2025-12-31 $567,680 135,809
2025-09-30 $290,835 88,400
2025-06-30 $104,353 73,489
2025-03-31 $135,636 91,031
2024-12-31 $75,378 67,302
2024-09-30 $63,936 67,302
2024-06-30 $65,042 41,166
2024-03-31 $79,103 54,554
2023-12-31 $76,712 57,248
2023-09-30 $81,292 57,248
2023-06-30 $65,835 57,248
2023-03-31 $82,503 77,834
2022-12-31 $62,752 41,285
2022-09-30 $86,093 40,610
2022-06-30 $63,452 47,353
2022-03-31 $113,669 53,872
2021-12-31 $224,409 60,488
2021-09-30 $286,600 57,435
2021-06-30 $385,937 59,193
2021-03-31 $311,517 45,213
2020-12-31 $503,216 49,335
2020-09-30 $178,440 50,983
2020-06-30 $202,194 40,520
2020-03-31 $79,515 23,387